Chameleon Biosciences

Founded in 2017, Chameleon Biosciences is a pre-clinical stage gene therapy company, developing a proprietary vector platform technology for repeated dosing.

Health and bioBerkeley SkyDeck

Website: chameleonbiosci.com.

X: @ChameleonBiosci · 19 followers.

Category: Health and bio.

On Recent Funding since: Sep 28, 2026.

Signals

X account@ChameleonBiosci · created Oct 15, 2021 (5 years old) · 19 followers

Website registeredMar 7, 2017 (9 years old)

Timeline

October 15, 2021
X account created
March 7, 2017
Website created
Batch 8
BBerkeley SkyDeck · batch
Source: skydeck.berkeley.edu

Investors

BBerkeley SkyDeckaccelerator

Companies like Chameleon Biosciences

AAkamis Bio$60M Series A · Dec 2024
FFuse Vectors$5M Pre Seed · Feb 2025
LLir TherapeuticsPre Seed · May 2026
AArsenal BiosciencesSeries B+ · Oct 2025
NNavion Neurosciences$10.8M Seed · Sep 2026
VViolet Therapeutics$4.75M Seed · May 2026

Sources and API

Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/chameleon-biosciences (get a free API key).